Physician profile
Mariah Pate
NPI 1700140639
$3,435.73
in general payments reported to CMS, 2019-2025
14 companies · $607 in 2025
The $607 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $380 · 2021: $1,473 · 2022: $124 · 2023: $307 · 2024: $158 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,755.75 | 2019-2025 | Xpress Loprofile, Fiagon Navigation Unit |
| Optinose US, INC. | $430.04 | 2019-2025 | |
| Forte Bio-Pharma LLC | $250.00 | 2020 | |
| Intersect Ent, INC. | $247.75 | 2020-2021 | |
| Glaxosmithkline, LLC. | $226.89 | 2024-2025 | Nucala, Trelegy Ellipta |
| Aerin Medical INC. | $180.86 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $93.99 | 2021-2025 | Dupixent |
| Conmed Corporation | $83.33 | 2022 | |
| Genzyme Corporation | $51.34 | 2019-2023 | |
| Acclarent, INC | $36.38 | 2023 | Trudi Nav Cable |
| Neurent Medical Limited | $24.42 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Kaleo, INC. | $23.67 | 2022 | |
| Phadia US INC. | $18.24 | 2025 | Immunocap |
| Smith+Nephew, INC. | $13.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariah Pate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.